<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Korean J Intern Med</journal-id><journal-id journal-id-type="iso-abbrev">Korean J. Intern. Med</journal-id><journal-id journal-id-type="publisher-id">KJIM</journal-id><journal-title-group><journal-title>The Korean Journal of Internal Medicine</journal-title></journal-title-group><issn pub-type="ppub">1226-3303</issn><issn pub-type="epub">2005-6648</issn><publisher><publisher-name>The Korean Association of Internal Medicine</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3932386</article-id><article-id pub-id-type="doi">10.3904/kjim.2014.29.1.126</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Eosinophilic organ infiltration without eosinophilia or direct parasite infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jang</surname><given-names>Il Young</given-names></name><xref ref-type="aff" rid="A1-kjim-29-126">1</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Young-Joo</given-names></name><xref ref-type="aff" rid="A1-kjim-29-126">1</xref></contrib><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Hyung Jin</given-names></name><xref ref-type="aff" rid="A1-kjim-29-126">1</xref></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Yunsik</given-names></name><xref ref-type="aff" rid="A1-kjim-29-126">1</xref></contrib><contrib contrib-type="author"><name><surname>Shin</surname><given-names>Eun-Hye</given-names></name><xref ref-type="aff" rid="A1-kjim-29-126">1</xref></contrib><contrib contrib-type="author"><name><surname>Kang</surname><given-names>Dong-Uk</given-names></name><xref ref-type="aff" rid="A1-kjim-29-126">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kim</surname><given-names>Tae-Bum</given-names></name><xref ref-type="aff" rid="A1-kjim-29-126">1</xref><xref ref-type="aff" rid="A2-kjim-29-126">2</xref></contrib></contrib-group><aff id="A1-kjim-29-126"><label>1</label>Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</aff><aff id="A2-kjim-29-126"><label>2</label>Division of Allergy and Clinical Immunology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</aff><author-notes><corresp>Correspondence to Tae-Bum Kim, M.D. Division of Allergy and Clinical Immunology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea. Tel: +82-2-3010-3280, Fax: +82-2-3010-6969, <email>allergy@medimail.co.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>02</day><month>1</month><year>2014</year></pub-date><volume>29</volume><issue>1</issue><fpage>126</fpage><lpage>129</lpage><history><date date-type="received"><day>09</day><month>5</month><year>2013</year></date><date date-type="rev-recd"><day>11</day><month>6</month><year>2013</year></date><date date-type="accepted"><day>22</day><month>7</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#xA9; 2014 The Korean Association of Internal Medicine</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><kwd-group><kwd>Eosinophilia</kwd><kwd>Parasites</kwd><kwd>Liver abscess</kwd></kwd-group></article-meta></front><body><p>To the Editor,</p><p>Eosinophilia is usually defined as the presence of more than 500 eosinophils/mm<sup>3</sup> in peripheral blood, and is often accompanied by tissue infiltration [<xref rid="B1-kjim-29-126" ref-type="bibr">1</xref>]. Massive eosinophil infiltration can generate an abscess or granuloma and result in tissue destruction [<xref rid="B2-kjim-29-126" ref-type="bibr">2</xref>]. Focal eosinophilic infiltrations are relatively common in the lung and liver, and are often associated with a parasitic infection, drug hypersensitivity, allergic disease, collagen vascular disease, or malignancy [<xref rid="B3-kjim-29-126" ref-type="bibr">3</xref>]. The presence of peripheral eosinophilia or evidence of direct parasite infestation can provide important insight to assess eosinophilic organ infiltration or abscesses. Most patients diagnosed with eosinophilic abscesses have peripheral blood eosinophilia. Some groups have reported that the number and extent of these foci seemed to be closely related to the eosinophil count in peripheral blood [<xref rid="B3-kjim-29-126" ref-type="bibr">3</xref>]. However, with the exception of eosinophilic infiltration in the gastrointestinal tract, for example in the esophagus or stomach, there have been no previous case reports of patients with eosinophilic organ infiltration without eosinophilia or direct parasitic infestation. Rather, most patients with eosinophilic organ infiltration have moderate to severe eosinophilia (&gt; 1,500/mm<sup>3</sup>), especial ly primary eosinophilia (clonal eosinophilia or idiopathic hypereosinophilic syndrome) [<xref rid="B3-kjim-29-126" ref-type="bibr">3</xref>,<xref rid="B4-kjim-29-126" ref-type="bibr">4</xref>]. Here, we report a case, detected during regular follow-up due to colon cancer, in a patient with a newly developed eosinophilic liver abscess proven by liver biopsy, and multiple cavitary lesions in both lungs without any evidence of eosinophilia or parasite infection.</p><p>A 55-year-old female had been diagnosed with ascending colon cancer and had undergone right hemicolectomy followed by six courses of adjuvant 5-fluorouracil chemotherapy. She was regularly followed-up by chest X-ray, abdominopelvic computed tomography (CT) scan, and laboratory tests, including complete blood count, chemistry, and tumor marker (carcinoembryonic antigen, CEA), every 6 months for 4 years at the cancer center in our hospital. There was no evidence of cancer recurrence.</p><p>At a recent regular visit, multiple newly developed small hepatic lesions in both hepatic lobes were detected on abdominopelvic CT. In addition, numerous cystic and cavitary lesions with multiple nodules were identif ied in both lungs on chest CT. These lesions in the liver and lung were not seen in previous CT scans. She was admitted for further evaluation because of suspected tumor metastasis. However, she had no subjective symptoms, such as itching or fever, and her Eastern Cooperative Oncology Group performance status was zero. No lesions suggestive of malignancy were seen on mammography or gynecological examination, and no skin lesions were revealed by physical examination. On admission, serum eosinophil count was 90/&#xB5;L, and there had been no eosinophilia for the 4 years since the initial diagnosis of colon cancer. In serological tests, antibodies to <italic>Toxocara</italic>, <italic>Clonorchis</italic>, <italic>Paragonimus</italic>, <italic>Cysticercus</italic>, and <italic>Sparganum</italic> all gave negative results, and serum total immunoglobulin E (IgE) was 108 kU/L. Serum CEA was 2.5 ng/mL and was constant.</p><p>Position emission tomography-CT confirmed the presence of multiple cavitary nodules in both lungs with mild hypermetabolic activity of SUVmax = ~1.2, at the same locations as the lesions seen in chest CT scans. However, there were no hypermetabolic lesions indicative of cancer recurrence or infection in the abdomen. Subsequently, ultrasonography-guided liver core-needle biopsy was performed, targeting the inferior segment of the right lobe where a hypoechoic mass-like lesion was seen. Pathological examination of the biopsy tissue revealed an eosinophilic abscess that contained no malignant cells (<xref ref-type="fig" rid="F1-kjim-29-126">Fig. 1</xref>). Immunohistochemical staining of the liver tissue also revealed no cells immunopositive for thyroid transcription factor-1, cytokeratin 20, or the homeobox protein CDX2 (a marker of intestinal differentiation). Biopsy confirmation of the multiple cavitary lesions was not possible because of their small size and the risk of complications.</p><p>In a review of past history, the patient denied eating any raw foods, such as bovine liver, minced raw beef, freshwater fishes, or herbal medication. The medication that she had been taking continuously for several years consisted of a &#x3B2;-blocker (bisoprolol), an angiotensin receptor blocker (losartan) for hypertension, and fenofibrate (procetofene) for dyslipidemia. In addition, she had not taken systemic corticosteroids that may have affected her eosinophil blood count during the six courses of 5-fluorouracil chemotherapy.</p><p>Although there was no evidence of malignancy in the liver biopsy, it was necessary to confirm that the infiltration was due to eosinophils. Therefore, we administered 30 mg of oral prednisolone twice per day for 14 days to determine whether the lesions contracted. In addition, 400 mg of albendazole twice per day for 2 weeks and 1,800 mg of praziquantel three times per day for 2 days were also administered because of the possibility of concurrent parasitic infection. When we performed chest and abdomen CT scans 1 month later, the primary liver lesion had decreased from 14 to 8 mm (<xref ref-type="fig" rid="F2-kjim-29-126">Fig. 2</xref>), and the number and size of lesions in the lungs were markedly reduced (<xref ref-type="fig" rid="F3-kjim-29-126">Fig. 3</xref>). After 3 months, CT showed that the lesions in the liver and lungs had almost disappeared without further medication. CT findings 2 years after the patient had presented with eosinophilic organ infiltration revealed no significant lesions in the liver or lungs.</p><p>Eosinophilia is often accompanied by eosinophilic organ infiltration, especially in the lungs and liver. Previous reports regarding eosinophilic infiltration of organs indicated that eosinophilic infiltration of the esophagus or stomach often occurs without evidence of eosinophilia. However, eosinophilic infiltration of internal organs other than the gastrointestinal tract is almost always accompanied by eosinophilia or direct parasitic infection. In the present case, eosinophilic infiltration of the liver and lungs occurred without any evidence of eosinophilia or direct parasitic infection.</p><p>Eosinophilic organ infiltration develops in two ways. In the first, it is a consequence of the eosinophilia itself. Moderate to severe eosinophilia often leads to organ infiltration, resulting in organ damage due to the release of cytotoxic granule proteins, such as eosinophil major basic protein and eosinophil cationic protein, as well as inflammatory lipid mediators [<xref rid="B3-kjim-29-126" ref-type="bibr">3</xref>,<xref rid="B4-kjim-29-126" ref-type="bibr">4</xref>]. Irrespective of the cause of the eosinophilic infiltration, the infiltrated organs are the skin, lungs, liver, brain, and most importantly the heart [<xref rid="B1-kjim-29-126" ref-type="bibr">1</xref>,<xref rid="B3-kjim-29-126" ref-type="bibr">3</xref>]. The other cause of eosinophilic organ infiltration is direct parasitic invasion. Some parasitic infections, such as fascioliasis and toxocariasis, produce focal lesions in the hepatic parenchyma due to either direct penetration or hematogenous migration to the liver. These lesions are caused by immature worms arrested during migration, and therefore they contain worms [<xref rid="B3-kjim-29-126" ref-type="bibr">3</xref>]. In the present case, there was no evidence of parasite infestation in the tissue biopsy.</p><p>Due to the patient's history of colon cancer, it was necessary to consider the possibility of cancer recurrence when newly developed multiple nodules were identified in the liver and lungs. There have been anecdotal reports of eosinophilic abscesses mistaken for metastasis and radiological reports of eosinophilic organ infiltration. The nodules in the liver in this case were single, small, and infrequent, consistent with our previous observation that eosinophilic infiltrations in cancer patients involve fewer and smaller nodules than metastatic nodules [<xref rid="B5-kjim-29-126" ref-type="bibr">5</xref>]. Although the lung lesions could not be confirmed by biopsy in this case, they shrank after treatment with oral corticosteroids, indicating that they must also have been eosinophilic infiltrations. In addition, the level of CEA, a marker of colon cancer, also tended to be constant.</p><p>As the patient had regularly undergone complete blood counts and abdominopelvic and chest CT scans, and had no previous history of systemic corticosteroid treatment, the eosinophilic infiltrations were clearly newly developed. However, their cause remains unclear. A diagnosis of hypereosinophilic syndrome is not appropriate as there was no eosinophilia. The likelihood of a causal relationship with the malignancy is very low, because there was no evidence of tumor recurrence. The possibility of parasite infestation was also low, considering the negative enzyme-linked immunosorbant assay findings, the absence of any history of ingestion of raw food, and the nearly normal serum levels of total IgE [<xref rid="B5-kjim-29-126" ref-type="bibr">5</xref>]. Consequently, we should bear in mind that eosinophilic infiltration in multiple organs can develop without blood eosinophilia or direct parasitic infestation, although its incidence is low.</p></body><back><fn-group><fn fn-type="conflict"><p>No potential conflict of interest relevant to this article is reported.</p></fn></fn-group><ref-list><ref id="B1-kjim-29-126"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tefferi</surname><given-names>A</given-names></name></person-group><article-title>Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment</article-title><source>Mayo Clin Proc</source><year>2005</year><volume>80</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">15667033</pub-id></element-citation></ref><ref id="B2-kjim-29-126"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito-Babapulle</surname><given-names>F</given-names></name></person-group><article-title>The eosinophilias, including the idiopathic hypereosinophilic syndrome</article-title><source>Br J Haematol</source><year>2003</year><volume>121</volume><fpage>203</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">12694242</pub-id></element-citation></ref><ref id="B3-kjim-29-126"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roufosse</surname><given-names>F</given-names></name><name><surname>Weller</surname><given-names>PF</given-names></name></person-group><article-title>Practical approach to the patient with hypereosinophilia</article-title><source>J Allergy Clin Immunol</source><year>2010</year><volume>126</volume><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">20538328</pub-id></element-citation></ref><ref id="B4-kjim-29-126"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>D</given-names></name><name><surname>Wardlaw</surname><given-names>A</given-names></name><name><surname>Rothenberg</surname><given-names>ME</given-names></name></person-group><article-title>Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract</article-title><source>J Allergy Clin Immunol</source><year>2010</year><volume>126</volume><fpage>3</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">20392477</pub-id></element-citation></ref><ref id="B5-kjim-29-126"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Yoon</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Clinical characteristics that distinguish eosinophilic organ infiltration from metastatic nodule development in cancer patients with eosinophilia</article-title><source>World J Surg Oncol</source><year>2012</year><volume>10</volume><fpage>175</fpage><pub-id pub-id-type="pmid">22929225</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1-kjim-29-126" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Pathological examination of the liver biopsy specimen revealed an eosinophilic abscess that contained no malignant cells (A, H&amp;E, &#xD7; 400; B, H&amp;E, &#xD7; 1,000).</p></caption><graphic xlink:href="kjim-29-126-g001"/></fig><fig id="F2-kjim-29-126" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Abdominal computed tomography scans. Black arrows indicate lesions with eosinophilic infiltration.</p></caption><graphic xlink:href="kjim-29-126-g002"/></fig><fig id="F3-kjim-29-126" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Chest computed tomography scans. The cystic and cavitary lesions with multiple nodules seen at diagnosis in both lungs improved over time.</p></caption><graphic xlink:href="kjim-29-126-g003"/></fig></floats-group></article>
